Screening for Intrapartum Fetal Compromise Using Placental Biomarkers
Recruiting
Observational Study
Pregnant Women
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 428 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the association between placental markers (sFlt-1, PlGF, and the sFlt-1/PlGF ratio) and intrapartum fetal compromise, assessed on the basis of the cardiotocographic tracing.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Gestational age ≥ 32 weeks
* Obtaining informed consent for participation in the study and for the processing of personal data
* Pregnant patients with an indication to perform placental marker testing as part of routine clinical practice
* Patients who will d…
Contacts